By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cylene Pharmaceuticals, Inc. 

5820 Nancy Ridge Drive, Suite 200

San Diego  California  92121  U.S.A.
Phone: 858-875-5100 Fax: 858-875-5101


SEARCH JOBS


Industry
Biotechnology






Company News
Cylene Pharmaceuticals, Inc. and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies 3/6/2013 9:32:34 AM
New Drug Stunts Tumor Growth, Cylene Pharmaceuticals, Inc. Reveals 7/18/2012 7:46:19 AM
Cylene Pharmaceuticals, Inc. Release: Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy 7/10/2012 10:59:18 AM
Cylene Pharmaceuticals, Inc. Builds on Success, Presents Second CK2 Inhibitor at American Association for Cancer Research Meeting 4/4/2012 9:37:38 AM
Cylene Pharmaceuticals, Inc. Builds on Success, Presents Second CK2 Inhibitor at American Association for Cancer Research Meeting 4/3/2012 11:24:27 AM
Cylene Pharmaceuticals, Inc. First-in-Class Agents Show Promise in High Risk Blood Cancers at American Society of Hematology 12/13/2011 11:04:14 AM
Cylene Pharmaceuticals, Inc. Advances Breakthrough p53 Activator Toward the Clinic 10/13/2011 10:29:55 AM
Cylene Pharmaceuticals, Inc. Presents Encouraging Clinical Data for Oral CK2 Inhibitor at American Society of Clinical Oncology 6/6/2011 10:23:59 AM
Cylene Pharmaceuticals, Inc. Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hypertension Meeting 12/6/2010 7:59:54 AM
Cylene Pharmaceuticals, Inc. to Present Advances with Industry's Only Clinical CK2 Inhibitor, CX-4945, at EORTC-NCI-AACR 11/16/2010 7:29:26 AM
1234
//-->